-
Mashup Score: 6Stella Immanuel Highest U.S. Prescriber of Ivermectin and HCQ - 1 year(s) ago
Controversial physician has doled out tens of thousands of scripts for both drugs
Source: www.medpagetoday.comCategories: Hem/Oncs, Latest HeadlinesTweet-
A bit unbelievable story- Consider the opportunity costs for either preventing or treating #COVID19 with evidence based therapies How is this possible? Freedom of practice vs. evidence care? Stella Immanuel Highest U.S. Prescriber of Ivermectin and HCQ https://t.co/djc1pGOCtb
-
-
Mashup Score: 0Protas partners with Duke Clinical Research Institute - 1 year(s) ago
Protas and Duke Clinical Research Institute have partnered to transform the quality, accessibility and affordability of randomized clinical trials for common health conditions.
Source: ProtasCategories: Cardiologists, Latest HeadlinesTweet-
Should smarter, fit-for-purpose clinical trials be a right for everyone? We think so! Very excited about this partnership with Protas & @MartinLandray: Protas partners with Duke Clinical Research Institute https://t.co/LOkWrBQD0L @DCRINews Stay tuned...
-
-
Mashup Score: 1At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19 - 1 year(s) ago
A Cochrane meta-analysis of 11 eligible trials examining the efficacy of ivermectin for the treatment of COVID-19 published through April 2022 concluded that ivermectin has no beneficial effect for people with COVID-19.1 Since May 2022, an additional 3 large randomized clinical trials including…
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
Important editor's note from @KBibbinsDomingo and Preeti Malani about the @ACTIV6study At a Higher Dose and Longer Duration, Ivermectin Still Not Effective Against COVID-19 https://t.co/bEEzy6bIlW via @JAMA_current part of @JAMANetwork
-
-
Mashup Score: 2Tracy Wang, MD, MHS, MSc Joins PCORI - 1 year(s) ago
PCORI is delighted to welcome Tracy Wang, MD, MHS, MSc as Chief, Comparative Clinical Effectiveness Research (CER). Wang will draw upon her clinical expertise as a cardiologist and her extensive research experience at the Duke Clinical Research Institute to provide strategic leadership and management of PCORI’s CER programs. Image “I am thrilled to…
Categories: Cardiologists, Latest HeadlinesTweet-
If you don't know @TYWangMD you should get to know her: Tracy Wang, MD, MHS, MSc Joins PCORI https://t.co/zhUgJy3Jvy She will have a big impact on US health and decisional dilemmas through #CER as chief of comparative effectiveness @PCORI @PCORnetwork
-
-
Mashup Score: 0UnitedHealthcare expecting $276B in revenue in 2023 - 1 year(s) ago
UnitedHealthcare expects 2023 revenues to be at least $274 billion.
Source: www.beckerspayer.comCategories: Cardiologists, Latest HeadlinesTweet-
Looks like one group has figured out to make the health care financial equation… @hmkyale UnitedHealthcare expecting $276B in revenue in 2023 https://t.co/M8ppF8PGzs
-
-
Mashup Score: 0Improving the Value of Information in Hospital Rating Systems - 2 year(s) ago
This Viewpoint uses US News & World Report’s annual hospital rankings to discuss how such efforts typically disadvantage hospitals caring for patients of lower socioeconomic status (SES) in regions with poorer population health, and argues for transparent and accurate ratings methods that use…
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
Completely agree- time is now. Our view a few years ago was rankings didn’t help drive the best practices…and could instead leave others behind Improving the Value of Information in Hospital Rating Systems https://t.co/TP2KvOWxou via @JAMA_current part of @JAMANetwork https://t.co/GozjBZcc7E
-
-
Mashup Score: 0
Citing flaws in the way the ratings are determined, the schools said they will stop participating, breaking away from the rankings industry.
Source: www.nytimes.comCategories: Cardiologists, Latest HeadlinesTweet-
Wonder if the same should be done for medical schools or grad schools or health systems. Are we implicitly promoting these structural biases by participating? via @NYTimes https://t.co/mEEULG9bEH
-
-
Mashup Score: 0
Some of the most vocal critics of science agencies like the NIH and the CDC, including Sen. Rand Paul, are poised for power if Republicans take control of Congress.
Source: STATCategories: Cardiologists, Latest HeadlinesTweet-
Trick or treat? With Republicans on the verge of congressional control, science is on the line https://t.co/uRXVlnAi3S via @statnews
-
-
Mashup Score: 3
This Viewpoint discusses the benefits of streamlined point-of-care trial designs in clinical research, using lessons learned from the UK RECOVERY study of dexamethasone dosing for patients with COVID-19 and hypoxia.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
What a great look into the future for #evidencegeneration and #clinicaltrials from @DrCaliff_FDA @FDACDERDirector and @US_FDA Lessons From the RECOVERY Study of Dexamethasone in COVID-19 and Hypoxia https://t.co/OwoEpHOjKa via @JAMAInternalMed part of @JAMANetwork
-
-
Mashup Score: 2PREVENTABLE - 2 year(s) ago
PREVENTABLE is one of the largest research studies in older adults. The purpose is to learn if taking a statin could help older adults live well for longer by preventing dementia, disability, or heart disease. A statin is a commonly used drug to lower cholesterol. …
Source: preventabletrial.orgCategories: Cardiologists, Latest HeadlinesTweet-
Getting back in person for investigator meetings is so much fun! We are approaching the 5000 milestone for #preventable RCT- the statin trial for healthy aging. Not the easiest launch at beginning of Covid especially for those 75 years and older https://t.co/FOiJ7ivYyx https://t.co/j26yWscvPM
-
In 2021, Stella Immanuel wrote over 69,000 prescriptions for hydroxychloroquine & almost 32,000 prescriptions for ivermectin. This continued in 2022, with 30,996 prescriptions for hydroxychloroquine & 16,085 for ivermectin. Why don’t medical boards act? https://t.co/U2KDYRjtYn